合成路线1
该中间体在本合成路线中的序号:
(XV) The reaction of 1,4-dithiane-2,5-diol (XII) with 2-(benzoyloxy)acetaldehyde (XIII) in hot pyridine gives 5-acetoxy-2-(benzoyloxymethyl)-1,3-oxathiolane (XIV), which is condensed with fully silylated cytosine (XV) (obtained by silylation of cytosine (XVI) with HMDS) by means of TBDMS-OTf, yielding, after acetylation with Ac2O, a mixture of the desired racemic-cis substituted fluorocytosine (XVII) along with its racemic trans isomer, which are separated by flash chromatography. The deacylation of (XVII) with ammonia in methanol gives the racemic cis-2-(hydroxymethyl)-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane (XVIII), which is phosphorylated with POCl3 and water in trimethyl phosphate yielding the racemic phosphate (XIX). The enantioselective dephosphorylation of (XIX) with 5'-nucleotidase (Sigma), affords a mixture of the (+)-(cis)-dephosphorylated compound (XXI) and unreacted (-)-(cis)-compound (XX) that are separated by column chromatography. Finally, (XX) is dephosphorylated by means of alkaline phosphatase (Sigma) to afford the target compound.
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(XII) |
36958 |
1,4-dithiane-2,5-diol
|
40018-26-6 |
C4H8O2S2 |
详情 | 详情
|
(XIII) |
15605 |
2-oxoethyl benzoate
|
|
C9H8O3 |
详情 |
详情
|
(XIV) |
36964 |
[5-(acetoxy)-1,3-oxathiolan-2-yl]methyl benzoate
|
|
C13H14O5S |
详情 |
详情
|
(XV) |
36959 |
5-fluoro-N-(trimethylsilyl)-2-[(trimethylsilyl)oxy]-4-pyrimidinamine; N-[5-fluoro-2-[(trimethylsilyl)oxy]-4-pyrimidinyl]-N-(trimethylsilyl)amine
|
|
C10H20FN3OSi2 |
详情 |
详情
|
(XVI) |
16747 |
4-amino-5-fluoro-2(1H)-pyrimidinone; 5-fluorocytosine |
2022-85-7 |
C4H4FN3O |
详情 | 详情
|
(XVII) |
36960 |
[(2R,5S)-5-[4-(acetamido)-5-fluoro-2-oxo-1(2H)-pyrimidinyl]-1,3-oxathiolan-2-yl]methyl benzoate
|
|
C17H16FN3O5S |
详情 |
详情
|
(XVIII) |
36961 |
4-amino-5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-2(1H)-pyrimidinone
|
|
C8H10FN3O3S |
详情 |
详情
|
(XIX) |
64685 |
(rac)-({(2R*,5S*)-5-[4-amino-5-fluoro-2-oxo-1(2H)-pyrimidinyl]-1,3-oxathiolan-2-yl}methyl dihydrogen phosphate)
|
|
C8H11FN3O6PS |
详情 |
详情
|
(XX) |
36962 |
[(2R,5S)-5-[4-amino-5-fluoro-2-oxo-1(2H)-pyrimidinyl]-1,3-oxathiolan-2-yl]methyl dihydrogen phosphate
|
|
C8H11FN3O6PS |
详情 |
详情
|
(XXI) |
36963 |
4-amino-5-fluoro-1-[(2S,5R)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-2(1H)-pyrimidinone
|
|
C8H10FN3O3S |
详情 |
详情
|
合成路线2
该中间体在本合成路线中的序号:
(XV) The acylation of 2-butene-1,4-diol (XXII) with butyryl chloride and DMAP in pyridine gives the dibutyrate (XXIII), which is ozonolyzed with O3 in dichloromethane yielding the aldehyde (XXIV). The cyclization of (XXIV) with mercaptoacetic acid (XXV) in refluxing toluene affords 2-(butyryloxymethyl)-1,3-oxathiolane-5-one (XXVI), which is reduced with lithium tri-tert-butoxyaluminum hydride and acetylated with acetic anhydride in THF to give 5-acetoxy-2-(butyryloxymethyl)-1,3-oxathiolane (XXVII). The condensation of (XXVII) with disilylated 5-fluorocytosine (XV) (obtained from cytosine (XVI) as described) by means of SnCl4 in dichloromethane yields the racemic butyryl nucleoside rac-(cis)-(XXVIII). The biological resolution of this racemic mixture has been performed by digestion with the enzyme pig liver esterase (PLE-A) providing a mixture of unreacted (-)-(cis)-(2R,5S)-(XXVIII) butyrate and hydrolyzed (+)-(cis)-(2S,5R)-(XXIX) that are separated by fractional extraction. The desired (-)-(cis)-(2R,5S)-enantiomer is finally hydrolyzed to the target compound with NaOMe in methanol.
The biological resolution of rac-(cis)-(XXVIII) can also be performed with the enzyme Amano PS-800 yielding a mixture of unreacted (+)-(cis)-(2S,5R)-(XXVIII) butyrate and the desired (-)-(cis)-(2R,5S) target nuceloside that are separated by fractional extraction.
【1】
Liotta, D.C.; Schinazi, R.F.; Choi, W.-B. (Emory University); Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1, 3-oxathiolane. EP 0984013; JP 1994508605; JP 1998147586; WO 9214743 .
|
【2】
Hoong, L.K.; et al.; Enzyme-mediated enantioselective preparation of pure enantiomers of the antiviral agent 2', 3'-dideoxy-5-fluoro-3'-thiacytidine (FTC) and related compounds. J Org Chem 1992, 57, 21, 5563.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(rac)-(XXVIII) |
36970 |
(rac)-[(2R,5S)-5-[4-amino-5-fluoro-2-oxo-1(2H)-pyrimidinyl]-1,3-oxathiolan-2-yl]methyl butyrate
|
|
C12H16FN3O4S |
详情 |
详情
|
(+)-(XXVIII) |
36971 |
[(2S,5R)-5-[4-amino-5-fluoro-2-oxo-1(2H)-pyrimidinyl]-1,3-oxathiolan-2-yl]methyl butyrate
|
|
C12H16FN3O4S |
详情 |
详情
|
(-)-cis-(XXVIII) |
36972 |
(-)-cis-[(2R,5S)-5-[4-amino-5-fluoro-2-oxo-1(2H)-pyrimidinyl]-1,3-oxathiolan-2-yl]methyl butyrate
|
|
C12H16FN3O4S |
详情 |
详情
|
(XV) |
36959 |
5-fluoro-N-(trimethylsilyl)-2-[(trimethylsilyl)oxy]-4-pyrimidinamine; N-[5-fluoro-2-[(trimethylsilyl)oxy]-4-pyrimidinyl]-N-(trimethylsilyl)amine
|
|
C10H20FN3OSi2 |
详情 |
详情
|
(XVI) |
16747 |
4-amino-5-fluoro-2(1H)-pyrimidinone; 5-fluorocytosine |
2022-85-7 |
C4H4FN3O |
详情 | 详情
|
(XXII) |
36965 |
(Z)-2-butene-1,4-diol
|
6117-80-2 |
C4H8O2 |
详情 | 详情
|
(XXIII) |
36966 |
(Z)-4-(butyryloxy)-2-butenyl butyrate
|
|
C12H20O4 |
详情 |
详情
|
(XXIV) |
36967 |
2-oxoethyl butyrate
|
|
C6H10O3 |
详情 |
详情
|
(XXV) |
18524 |
2-sulfanylacetic acid
|
68-11-1 |
C2H4O2S |
详情 | 详情
|
(XXVI) |
36968 |
(5-oxo-1,3-oxathiolan-2-yl)methyl butyrate
|
|
C8H12O4S |
详情 |
详情
|
(XXVII) |
36969 |
[5-(acetoxy)-1,3-oxathiolan-2-yl]methyl butyrate
|
|
C10H16O5S |
详情 |
详情
|
(XXIX) |
36963 |
4-amino-5-fluoro-1-[(2S,5R)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-2(1H)-pyrimidinone
|
|
C8H10FN3O3S |
详情 |
详情
|
合成路线3
该中间体在本合成路线中的序号:
(IX) A new process for the preparation of emtricitabine has been described: The esterification of 2-butene-1,4-diol (I) with butyryl chloride and DMAP in pyridine gives the diester (II), which by ozonolysis with O3 in methanol provides the hemiacetal (III). Cyclization of (III) with 2-mercaptoacetic acid in refluxing toluene affords racemic 2-(butyryloxymethyl)-1,3-oxathiolan-5-one (V), which is submitted to optical resolution to afford the (R)-enantiomer (VI). The reduction of (VI) with Li(t-BuO)3AlH, followed by acetylation with acetic anhydride gives 5-(acetoxy)-2(R)-(butyryloxy)-1,3-oxathiolane (VII), which by treatment with HCl in dichloroethane is converted into 2(R)-(butyryloxy)-5-chloro-1,3-oxathiolane (VIII). Condensation of (VIII) with 5-fluoro-bis(trimethylsilyl)cytosine (IX) obtained by silylation of cytosine (X) with HMDS by means of NaHCO3 in dichloroethane gives a diastereomeric mixture of the butyrate nucleosides (XI), which is hydrolyzed with butylamine in methanol yielding the corresponding diastereomeric mixture of the (2R,5S)-isomer, emtricitabine, and the (2R,5R)-isomer (XII). This mixture is separated by crystallization of the corresponding hydrochlorides obtained by treatment with HCl in methanol/dioxane.
【1】
Almond, M.; Painter, G.R.; Liotta, D.C.; Cleary, D.; Soria, J. (Emory University; Triangle Pharmaceuticals, Inc.); Method of manufacture of 1,3-oxathiolane nucleosides. WO 0009494 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
36965 |
(Z)-2-butene-1,4-diol
|
6117-80-2 |
C4H8O2 |
详情 | 详情
|
(II) |
36966 |
(Z)-4-(butyryloxy)-2-butenyl butyrate
|
|
C12H20O4 |
详情 |
详情
|
(III) |
39681 |
2-hydroxy-2-methoxyethyl butyrate
|
|
C7H14O4 |
详情 |
详情
|
(IV) |
18524 |
2-sulfanylacetic acid
|
68-11-1 |
C2H4O2S |
详情 | 详情
|
(V) |
36968 |
(5-oxo-1,3-oxathiolan-2-yl)methyl butyrate
|
|
C8H12O4S |
详情 |
详情
|
(VI) |
39682 |
[(2R)-5-oxo-1,3-oxathiolan-2-yl]methyl butyrate
|
|
C8H12O4S |
详情 |
详情
|
(VII) |
39683 |
[(2R)-5-(acetoxy)-1,3-oxathiolan-2-yl]methyl butyrate
|
|
C10H16O5S |
详情 |
详情
|
(VIII) |
39685 |
[(2R)-5-chloro-1,3-oxathiolan-2-yl]methyl butyrate
|
|
C8H13ClO3S |
详情 |
详情
|
(IX) |
36959 |
5-fluoro-N-(trimethylsilyl)-2-[(trimethylsilyl)oxy]-4-pyrimidinamine; N-[5-fluoro-2-[(trimethylsilyl)oxy]-4-pyrimidinyl]-N-(trimethylsilyl)amine
|
|
C10H20FN3OSi2 |
详情 |
详情
|
(X) |
16747 |
4-amino-5-fluoro-2(1H)-pyrimidinone; 5-fluorocytosine |
2022-85-7 |
C4H4FN3O |
详情 | 详情
|
(XI) |
36970 |
(rac)-[(2R,5S)-5-[4-amino-5-fluoro-2-oxo-1(2H)-pyrimidinyl]-1,3-oxathiolan-2-yl]methyl butyrate
|
|
C12H16FN3O4S |
详情 |
详情
|
(XII) |
36984 |
benzyl 6-oxo-5,6,7,8-tetrahydro-2-naphthalenylcarbamate
|
|
C18H17NO3 |
详情 |
详情
|
合成路线4
该中间体在本合成路线中的序号:
(X) The reaction of D-glutamic acid (I) with NaNO2 and HCl gives the lactone carboxylic acid (II), which is esterified with EtOH and Ts-OH to yield the ester (III), reduced with NaBH4 in ethanol and silylated with Tbdps-Cl and imidazole to afford the protected chiral lactone (IV). The selenation of lactone (IV) with N-(phenylseleno)phthalimide (V) by means of LiHMDS and Tms-Cl in THF gives a mixture of diastereomers with a higher ratio (3:1) of the desired isomer (VI). (The unwanted isomer (VII) can be isomerized by reaction with DBU in THF.) The reduction of the lactone (VI) with DIBAL in toluene affords the lactol (VIII), which is treated with Ac2O and TEA to provide the acetoxy compound (IX). The condensation of (IX) with 5-fluoro-N,O-bis(trimethylsilyl)cytosine (X) by means of Tms-OTf in dichloromethane gives the selenated cytosine derivative (XI), which is treated with H2O2 in THF/pyridine to yield the unsaturated silylated precursor (XII). Finally, this compound is desilylated with HF and TEA in THF to afford the target cytosine derivative.
【1】
Bayes, M.; Sorbera, L.A.; Castaner, J.; ACH-126443. Drugs Fut 2002, 27, 12, 1131.
|
【2】
Chen, S.-H.; et al.; Stereoselective syntheses of beta-L-FD4C and beta-L-FddC. J Org Chem 1997, 62, 11, 3449.
|
【3】
Chen, S.-H.; Xiuyan, L. (Vion Pharmaceuticals, Inc.); Processes for high-yield diastereoselective synthesis of dideoxynucleosides. WO 9747635 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
54708 |
(R)-(-)-Glutamic acid; (R)-2-Aminoglutaric acid; D-(+)-Glutamic acid; D-2-Aminoglutaric acid; D-glutamic acid
|
6893-26-1 |
C5H9NO4 |
详情 | 详情
|
(II) |
12006 |
(R)-(-)-5-Oxo-2-tetrahydrofurancarboxylic acid; (2S)-5-oxotetrahydro-2-furancarboxylic acid
|
53558-93-3 |
C5H6O4 |
详情 | 详情
|
(III) |
12007 |
ethyl (2S)-5-oxotetrahydro-2-furancarboxylate; (S)-(+)-gamma-Ethoxycarbonyl-gamma-butyrolactone
|
55094-96-7 |
C7H10O4 |
详情 | 详情
|
(IV) |
56922 |
(5R)-5-({[tert-butyl(diphenyl)silyl]oxy}methyl)dihydro-2(3H)-furanone
|
|
C21H26O3Si |
详情 |
详情
|
(V) |
54701 |
N-(Phenylseleno)phthalimide
|
71098-88-9 |
C14H9NO2Se |
详情 | 详情
|
(VI) |
54702 |
(4R,5S)-5-({[tert-butyl(diphenyl)silyl]oxy}methyl)-4-(phenylselanyl)dihydro-2(3H)-furanone
|
|
C27H30O3SeSi |
详情 |
详情
|
(VII) |
54703 |
(4S,5S)-5-({[tert-butyl(diphenyl)silyl]oxy}methyl)-4-(phenylselanyl)dihydro-2(3H)-furanone
|
|
C27H30O3SeSi |
详情 |
详情
|
(VIII) |
54704 |
(4R,5S)-5-({[tert-butyl(diphenyl)silyl]oxy}methyl)-4-(phenylselanyl)tetrahydro-2-furanol
|
|
C27H32O3SeSi |
详情 |
详情
|
(IX) |
54705 |
(4R,5S)-5-({[tert-butyl(diphenyl)silyl]oxy}methyl)-4-(phenylselanyl)tetrahydro-2-furanyl acetate
|
|
C29H34O4SeSi |
详情 |
详情
|
(X) |
36959 |
5-fluoro-N-(trimethylsilyl)-2-[(trimethylsilyl)oxy]-4-pyrimidinamine; N-[5-fluoro-2-[(trimethylsilyl)oxy]-4-pyrimidinyl]-N-(trimethylsilyl)amine
|
|
C10H20FN3OSi2 |
详情 |
详情
|
(XI) |
54706 |
4-amino-1-[(2S,4R,5S)-5-({[tert-butyl(diphenyl)silyl]oxy}methyl)-4-(phenylselanyl)tetrahydro-2-furanyl]-5-fluoro-2(1H)-pyrimidinone
|
|
C31H34FN3O3SeSi |
详情 |
详情
|
(XII) |
54707 |
4-amino-1-[(2S,5R)-5-({[tert-butyl(diphenyl)silyl]oxy}methyl)-2,5-dihydro-2-furanyl]-5-fluoro-2(1H)-pyrimidinone
|
|
C25H28FN3O3Si |
详情 |
详情
|
合成路线5
该中间体在本合成路线中的序号:
(V) The acylation of 2,3-O-isopropylidene-alpha-D-xylofuranose (I) with benzoyl chloride and pyridine gives the dibenzoyl ester (II), which is deprotected by means of H2SO4/HOAc in hot THF to yield 3,5-di-O-benzoyl-alpha-D-xylofuranose (III). The reaction of (III) with PPh3, I2 and imidazole in dichloromethane affords the glycal (IV), which is used in the glycosylation of the N,O-disilylated 5-fluorocytosine (V) by means of NIS in dichloromethane to provide the 2'-alpha-iodonucleoside (VI). The treatment of (VI) with Zn in EtOH/ethyl acetate (HOAc is used as catalyst) gives the unsaturated nucleoside (VII), which is finally debenzoylated by means of butylamine in THF.
【1】
Chen, S.-H.; Lin, S.; King, I.; Spinka, T.; Dutschman, G.E.; Gullen, E.A.; Cheng, Y.-C.; Doyle, T.W.; Synthesis and comparative evaluation of two antiviral agents: beta-L-Fd4C and beta-D-Fd4C. Bioorg Med Chem Lett 1998, 8, 22, 3245.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
41907 |
(3aR,5R,6S,6aR)-5-(hydroxymethyl)-2,2-dimethyltetrahydrofuro[2,3-d][1,3]dioxol-6-ol
|
20031-21-4 |
C8H14O5 |
详情 | 详情
|
(II) |
56701 |
[(3aR,5R,6S,6aR)-6-(benzoyloxy)-2,2-dimethyltetrahydrofuro[2,3-d][1,3]dioxol-5-yl]methyl benzoate
|
|
C22H22O7 |
详情 |
详情
|
(III) |
56702 |
[(2R,3R,4R,5S)-3-(benzoyloxy)-4,5-dihydroxytetrahydro-2-furanyl]methyl benzoate
|
|
C19H18O7 |
详情 |
详情
|
(IV) |
56703 |
[(2R,3R)-3-(benzoyloxy)-2,3-dihydro-2-furanyl]methyl benzoate
|
|
C19H16O5 |
详情 |
详情
|
(V) |
36959 |
5-fluoro-N-(trimethylsilyl)-2-[(trimethylsilyl)oxy]-4-pyrimidinamine; N-[5-fluoro-2-[(trimethylsilyl)oxy]-4-pyrimidinyl]-N-(trimethylsilyl)amine
|
|
C10H20FN3OSi2 |
详情 |
详情
|
(VI) |
56704 |
[(2R,3S,4R,5R)-5-[4-amino-5-fluoro-2-oxo-1(2H)-pyrimidinyl]-3-(benzoyloxy)-4-iodotetrahydro-2-furanyl]methyl benzoate
|
|
C23H19FIN3O6 |
详情 |
详情
|
(VII) |
56705 |
{(2S,5R)-5-[4-amino-5-fluoro-2-oxo-1(2H)-pyrimidinyl]-2,5-dihydro-2-furanyl}methyl benzoate
|
|
C16H14FN3O4 |
详情 |
详情
|
合成路线6
该中间体在本合成路线中的序号:
(II) The condensation of the known acetate (I) with N,O-disylilated cytosine (II) by means of Tms-OTf or SnCl4 gives the selenium containing nucleoside (III), which is submitted to an oxidative elimination reaction by means of H2O2 and pyridine in dichloromethane to yield the unsaturated nucleoside (IV). Finally, this compound is desilylated by means of TBAF in THF.
【1】
Shi, J.; et al.; Synthesis and biological evaluation of 2',3'-didehydro-2',3'-dideoxy-5-fluorocytidine (D4FC) analogues: Discovery of carbocyclic nucleoside triphosphates with potent inhibitory activity against HIV-1 reverse transcriptase. J Med Chem 1999, 42, 5, 859. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
12217 |
(3R,5S)-5-([[tert-butyl(diphenyl)silyl]oxy]methyl)-3-(phenylselanyl)tetrahydro-2-furanyl acetate
|
|
C29H34O4SeSi |
详情 |
详情
|
(II) |
36959 |
5-fluoro-N-(trimethylsilyl)-2-[(trimethylsilyl)oxy]-4-pyrimidinamine; N-[5-fluoro-2-[(trimethylsilyl)oxy]-4-pyrimidinyl]-N-(trimethylsilyl)amine
|
|
C10H20FN3OSi2 |
详情 |
详情
|
(III) |
56706 |
1-[(2R,3R,5S)-5-({[tert-butyl(diphenyl)silyl]oxy}methyl)-3-(phenylselanyl)tetrahydro-2-furanyl]-5-fluoro-4-[(trimethylsilyl)amino]-2(1H)-pyrimidinone
|
|
C34H42FN3O3SeSi2 |
详情 |
详情
|
(IV) |
56707 |
1-[(2R,5S)-5-({[tert-butyl(diphenyl)silyl]oxy}methyl)-2,5-dihydro-2-furanyl]-5-fluoro-4-[(trimethylsilyl)amino]-2(1H)-pyrimidinone
|
|
C28H36FN3O3Si2 |
详情 |
详情
|
合成路线7
该中间体在本合成路线中的序号:
(I) The silylated 5-fluorocytosine (I) is coupled with D-ribofuranose tetraacetate (II) in the presence of SnCl4 in acetonitrile to afford the triacetyl 5-fluorocytidine (III). Acylation of (III) with allyl chloroformate (IV) yields carbamate (V). Then, methanolysis of the acetate ester groups of (V) provides 5-fluoro-N-(allyloxycarbonyl)cytidine (VI). Finally, selective oxidation of the primary alcohol group of (VI) with oxygen and PtO2 gives the target carboxylic acid
【1】
Kim, K.-H.; Kim, J.-Y; Lee, K-H; Noh, M.-J.; Kim, Y.-C.; Park, H.-J.; Synthesis and biological activity of the new 5-fluorocytosine derivatives, 5'-deoxy-N-alkyloxycarbonyl-5-fluorocytosine-5'-carboxylic acid. Bioorg Med Chem Lett 2002, 12, 3, 483.
|
【2】
Lee, K.-H.; Kim, J.-Y.; Kim, Y.-C.; Kim, K.-H.; Park, H.-J.; Noh, M.-J.; Park, Y.-S.; Cho, S.-M. (Kolon Industries, Inc.); 5'-Deoxy-N-(substd. oxycarbonyl)-5-fluorocytosine and derivs. thereof, method of preparing same, and anticancer compsn. comprising same as active ingredients. WO 0211668 . |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
36959 |
5-fluoro-N-(trimethylsilyl)-2-[(trimethylsilyl)oxy]-4-pyrimidinamine; N-[5-fluoro-2-[(trimethylsilyl)oxy]-4-pyrimidinyl]-N-(trimethylsilyl)amine
|
|
C10H20FN3OSi2 |
详情 |
详情
|
(II) |
33835 |
(2R,3R,4R,5S)-4,5-bis(acetoxy)-2-[(acetoxy)methyl]tetrahydro-3-furanyl acetate
|
13035-61-5 |
C13H18O9 |
详情 | 详情
|
(III) |
60387 |
(2R,3R,4R,5R)-4-(acetyloxy)-2-[(acetyloxy)methyl]-5-[4-amino-5-fluoro-2-oxo-1(2H)-pyrimidinyl]tetrahydro-3-furanyl acetate
|
|
C15H18FN3O8 |
详情 |
详情
|
(IV) |
38115 |
3-[(chlorocarbonyl)oxy]-1-propene
|
2937-50-0 |
C4H5ClO2 |
详情 | 详情
|
(V) |
60388 |
(2R,3R,4R,5R)-4-(acetyloxy)-2-[(acetyloxy)methyl]-5-[4-{[(allyloxy)carbonyl]amino}-5-fluoro-2-oxo-1(2H)-pyrimidinyl]tetrahydro-3-furanyl acetate
|
|
C19H22FN3O10 |
详情 |
详情
|
(VI) |
60389 |
allyl 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]-5-fluoro-2-oxo-1,2-dihydro-4-pyrimidinylcarbamate
|
|
C13H16FN3O7 |
详情 |
详情
|
合成路线8
该中间体在本合成路线中的序号:
(IX)
【1】
Mansour T,Jin H.et al.1997.Processes for the diastereoselective synthesisof nucleoside analogues. US 5696254 |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
36958 |
1,4-dithiane-2,5-diol
|
40018-26-6 |
C4H8O2S2 |
详情 | 详情
|
(II) |
15618 |
2-Oxoacetic acid; Glyoxylic Acid
|
298-12-4 |
C2H2O3 |
详情 | 详情
|
(III) |
66301 |
(2S,5R)-5-hydroxy-1,3-oxathiolane-2-carboxylic acid |
|
C4H6O4S |
详情 | 详情
|
(IV) |
66302 |
(2R,5R)-5-hydroxy-1,3-oxathiolane-2-carboxylic acid |
147027-04-1 |
C4H6O4S |
详情 | 详情
|
(V) |
15620 |
(2R,5R)-5-(acetoxy)-1,3-oxathiolane-2-carboxylic acid
|
147027-05-2 |
C6H8O5S |
详情 | 详情
|
(VI) |
66303 |
(2R,5S)-2-isopropyl-5-methylcyclohexanol |
|
C10H20O |
详情 | 详情
|
(VII) |
55067 |
(1R,2S,5R)-2-isopropyl-5-methylcyclohexyl (2R,5R)-5-(acetyloxy)-1,3-oxathiolane-2-carboxylate
|
|
C16H26O5S |
详情 |
详情
|
(VIII) |
66304 |
|
|
C16H26O5S |
详情 | 详情
|
(IX) |
36959 |
5-fluoro-N-(trimethylsilyl)-2-[(trimethylsilyl)oxy]-4-pyrimidinamine; N-[5-fluoro-2-[(trimethylsilyl)oxy]-4-pyrimidinyl]-N-(trimethylsilyl)amine
|
|
C10H20FN3OSi2 |
详情 |
详情
|
(X) |
66305 |
(2S,5R)-(1S,2R,5S)-2-isopropyl-5-methylcyclohexyl 5-(4-amino-5-fluoro-2-oxopyrimidin-1(2H)-yl)-1,3-oxathiolane-2-carboxylate |
|
C18H26FN3O4S |
详情 | 详情
|
合成路线9
该中间体在本合成路线中的序号:
(VIII)
【1】
Liotta DC, Schinazi RF, et al.1993. The preparation of 2'-deoxy-5-fluoro-3'-thiacytidine and related compounds as anti-HIV nucleosides. US 5210085 |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
12234 |
2-Propen-1-ol; Allyl alcohol
|
107-18-6 |
C3H6O |
详情 | 详情
|
(II) |
66313 |
tert-Butylchlorodiphenylsilane;tert-Butyldiphenylchlorosilane;tert-Butyldiphenylsilyl chloride |
58479-61-1 |
C16H19ClSi |
详情 | 详情
|
(III) |
66314 |
(allyloxy)(tert-butyl)diphenylsilane |
|
C19H24OSi |
详情 | 详情
|
(IV) |
44475 |
2-[[tert-butyl(diphenyl)silyl]oxy]acetaldehyde
|
|
C18H22O2Si |
详情 |
详情
|
(V) |
18524 |
2-sulfanylacetic acid
|
68-11-1 |
C2H4O2S |
详情 | 详情
|
(VI) |
66315 |
2-(((tert-butyldiphenylsilyl)oxy)methyl)-1,3-oxathiolan-5-one |
|
C20H24O3SSi |
详情 | 详情
|
(VII) |
55072 |
(2R)-2-({[tert-butyl(diphenyl)silyl]oxy}methyl)-1,3-oxathiolan-4-yl acetate
|
|
C22H28O4SSi |
详情 |
详情
|
(VIII) |
36959 |
5-fluoro-N-(trimethylsilyl)-2-[(trimethylsilyl)oxy]-4-pyrimidinamine; N-[5-fluoro-2-[(trimethylsilyl)oxy]-4-pyrimidinyl]-N-(trimethylsilyl)amine
|
|
C10H20FN3OSi2 |
详情 |
详情
|
(IX) |
66316 |
4-amino-1-((2S,5R)-2-(((tert-butyldiphenylsilyl)oxy)methyl)-1,3-oxathiolan-5-yl)-5-fluoropyrimidin-2(1H)-one |
|
C24H28FN3O3SSi |
详情 | 详情
|
合成路线10
该中间体在本合成路线中的序号:
(VIII)
【1】
Ren D.2005.Inclustrial scale preparation of emtricitabine.发明专利申请公开说明书,CN 1563002 |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(VIII) |
36959 |
5-fluoro-N-(trimethylsilyl)-2-[(trimethylsilyl)oxy]-4-pyrimidinamine; N-[5-fluoro-2-[(trimethylsilyl)oxy]-4-pyrimidinyl]-N-(trimethylsilyl)amine
|
|
C10H20FN3OSi2 |
详情 |
详情
|
(I) |
36958 |
1,4-dithiane-2,5-diol
|
40018-26-6 |
C4H8O2S2 |
详情 | 详情
|
(II) |
15618 |
2-Oxoacetic acid; Glyoxylic Acid
|
298-12-4 |
C2H2O3 |
详情 | 详情
|
(VI) |
66303 |
(2R,5S)-2-isopropyl-5-methylcyclohexanol |
|
C10H20O |
详情 | 详情
|
(X) |
66305 |
(2S,5R)-(1S,2R,5S)-2-isopropyl-5-methylcyclohexyl 5-(4-amino-5-fluoro-2-oxopyrimidin-1(2H)-yl)-1,3-oxathiolane-2-carboxylate |
|
C18H26FN3O4S |
详情 | 详情
|
(XI) |
66306 |
(2R,5S)-2-isopropyl-5-methylcyclohexyl 2-oxoacetate |
|
C12H20O3 |
详情 | 详情
|
(XII) |
66308 |
(5R)-(1S,2R,5S)-2-isopropyl-5-methylcyclohexyl 5-hydroxy-1,3-oxathiolane-2-carboxylate |
|
C14H24O4S |
详情 | 详情
|
(XIII) |
66307 |
(5R)-(1S,2R,5S)-2-isopropyl-5-methylcyclohexyl 5-hydroxy-1,3-oxathiolane-2-carboxylate |
|
C16H26O5S |
详情 | 详情
|
合成路线11
该中间体在本合成路线中的序号:
(VIII)
【1】
Richhariya S.Singh K, et aL 2007.Process for the preparation of crystalline l-menthyl (ZR.5S)-5-( 4-amino-5-fluoro-2-oxo-2H-pyrimidin-1-yl)[1,3]oxathiolanr2-carboxylate. W0 2007077505 |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(VIII) |
36959 |
5-fluoro-N-(trimethylsilyl)-2-[(trimethylsilyl)oxy]-4-pyrimidinamine; N-[5-fluoro-2-[(trimethylsilyl)oxy]-4-pyrimidinyl]-N-(trimethylsilyl)amine
|
|
C10H20FN3OSi2 |
详情 |
详情
|
(X) |
66305 |
(2S,5R)-(1S,2R,5S)-2-isopropyl-5-methylcyclohexyl 5-(4-amino-5-fluoro-2-oxopyrimidin-1(2H)-yl)-1,3-oxathiolane-2-carboxylate |
|
C18H26FN3O4S |
详情 | 详情
|
(XII) |
66308 |
(5R)-(1S,2R,5S)-2-isopropyl-5-methylcyclohexyl 5-hydroxy-1,3-oxathiolane-2-carboxylate |
|
C14H24O4S |
详情 | 详情
|
(XIV) |
66309 |
(5R)-(1S,2R,5S)-2-isopropyl-5-methylcyclohexyl 5-chloro-1,3-oxathiolane-2-carboxylate |
|
C14H23ClO3S |
详情 | 详情
|